Van Lanschot Kempen Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.6M | Sell |
331,836
-191,123
| -37% | -$22.4M | 0.33% | 52 |
|
|
2026
Q1 | $62.9M | Sell |
522,959
-1,656
| -0.3% | -$191K | 0.55% | 29 |
|
|
2025
Q4 | $55.2M | Sell |
524,615
-82,120
| -14% | -$7.71M | 0.47% | 33 |
|
|
2025
Q3 | $50.9M | Buy |
606,735
+27,831
| +5% | +$2.29M | 0.45% | 38 |
|
|
2025
Q2 | $45.8M | Buy |
578,904
+75,696
| +15% | +$6.02M | 0.44% | 39 |
|
|
2025
Q1 | $45.2M | Sell |
503,208
-1,292,388
| -72% | -$121M | 0.47% | 48 |
|
|
2024
Q4 | $179M | Sell |
1,795,596
-4,954
| -0.3% | -$511K | 1.78% | 10 |
|
|
2024
Q3 | $204M | Buy |
1,800,550
+227
| +0% | +$27K | 2.08% | 8 |
|
|
2024
Q2 | $223M | Buy |
1,800,323
+64,561
| +4% | +$8.32M | 2.5% | 8 |
|
|
2024
Q1 | $229M | Buy |
1,735,762
+7,245
| +0.4% | +$893K | 2.85% | 5 |
|
|
2023
Q4 | $188M | Buy |
1,728,517
+248,027
| +17% | +$25.7M | 2.63% | 5 |
|
|
2023
Q3 | $152M | Buy |
1,480,490
+196,007
| +15% | +$21.1M | 2.82% | 5 |
|
|
2023
Q2 | $148M | Buy |
1,284,483
+9,226
| +0.7% | +$1.05M | 2.67% | 3 |
|
|
2023
Q1 | $136M | Buy |
1,275,257
+955,546
| +299% | +$103M | 2.58% | 3 |
|
|
2022
Q4 | $35.5M | Buy |
319,711
+59,872
| +23% | +$6.12M | 1.03% | 36 |
|
|
2022
Q3 | $22.4M | Sell |
259,839
-46,426
| -15% | -$4.14M | 0.9% | 35 |
|
|
2022
Q2 | $27.9M | Sell |
306,265
-70,050
| -19% | -$6.21M | 1% | 35 |
|
|
2022
Q1 | $30.9M | Sell |
376,315
-9,540
| -2% | -$752K | 0.94% | 33 |
|
|
2021
Q4 | $29.6M | Buy |
385,855
+31,281
| +9% | +$2.49M | 0.92% | 32 |
|
|
2021
Q3 | $26.6M | Buy |
354,574
+4,515
| +1% | +$343K | 0.96% | 30 |
|
|
2021
Q2 | $27.2M | Sell |
350,059
-2,464
| -0.7% | -$183K | 0.97% | 33 |
|
|
2021
Q1 | $25.9M | Buy |
352,523
+176,120
| +100% | +$13M | 1.19% | 26 |
|
|
2020
Q4 | $13.8M | Buy |
176,403
+24,193
| +16% | +$1.85M | 0.8% | 55 |
|
|
2020
Q3 | $12M | Sell |
152,210
-115,891
| -43% | -$9.08M | 0.92% | 48 |
|
|
2020
Q2 | $19.8M | Buy |
268,101
+2,314
| +0.9% | +$174K | 1.45% | 13 |
|
|
2020
Q1 | $19.5M | Buy |
265,787
+234,464
| +749% | +$18.4M | 1.62% | 4 |
|
|
2019
Q4 | $2.72M | Buy |
31,323
+21,231
| +210% | +$1.74M | 0.17% | 105 |
|
|
2019
Q3 | $811K | Sell |
10,092
-852
| -8% | -$68.3K | 0.06% | 126 |
|
|
2019
Q2 | $876K | Sell |
10,944
-6,225
| -36% | -$477K | 0.08% | 129 |
|
|
2019
Q1 | $1.36M | Buy |
+17,169
| New | +$1.28M | 0.12% | 117 |
|
|
2018
Q3 | – | Sell |
-383,673
| Closed | -$22.2M | – | 158 |
|
|
2018
Q2 | $22.2M | Sell |
383,673
-102,136
| -21% | -$5.76M | 1.66% | 20 |
|
|
2018
Q1 | $25.3M | Sell |
485,809
-20,516
| -4% | -$1.11M | 2.03% | 10 |
|
|
2017
Q4 | $27.2M | Buy |
506,325
+458,751
| +964% | +$25.4M | 2.15% | 11 |
|
|
2017
Q3 | $2.91M | Buy |
47,574
+1,243
| +3% | +$75.4K | 0.22% | 113 |
|
|
2017
Q2 | $2.83M | Hold |
46,331
| – | – | 0.27% | 82 |
|
|
2017
Q1 | $2.81M | Buy |
46,331
+17,459
| +60% | +$1.06M | 0.32% | 59 |
|
|
2016
Q4 | $1.62M | Sell |
28,872
-1,782
| -6% | -$104K | 0.2% | 86 |
|
|
2016
Q3 | $1.82M | Sell |
30,654
-352,893
| -92% | -$20.6M | 0.24% | 66 |
|
|
2016
Q2 | $21.1M | Sell |
383,547
-70,185
| -15% | -$3.74M | 2.48% | 13 |
|
|
2016
Q1 | $22.9M | Sell |
453,732
-10,532
| -2% | -$516K | 2.61% | 13 |
|
|
2015
Q4 | $23.4M | Buy |
+464,264
| New | +$23.4M | 2.69% | 14 |
|
|
2015
Q1 | – | Sell |
-19,283
| Closed | -$1.04M | – | 130 |
|
|
2014
Q4 | $1.04M | Sell |
19,283
-3,563
| -16% | -$199K | 0.11% | 75 |
|
|
2014
Q3 | $1.29M | Sell |
22,846
-602,967
| -96% | -$33.9M | 0.13% | 52 |
|
|
2014
Q2 | $34.5M | Sell |
625,813
-150,755
| -19% | -$8.22M | 3.35% | 16 |
|
|
2014
Q1 | $42.1M | Sell |
776,568
-237,435
| -23% | -$12.3M | 4% | 5 |
|
|
2013
Q4 | $49.4M | Buy |
+1,014,003
| New | +$46.4M | 4.13% | 2 |
|
Other funds holding MRK
Van Lanschot Kempen Investment Management's MRK Position: Q2 2026 in Review
Van Lanschot Kempen Investment Management reduced its Merck (MRK) stake by 37% in Q2 2026, selling an estimated $22.4M and leaving 331,836 shares worth $42.6M. The position accounts for 0.33% of the portfolio, ranked #52.
Van Lanschot Kempen Investment Management first reported a position in MRK in Q4 2013 and has held it in 46 quarters since. The position peaked at $229M in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Van Lanschot Kempen Investment Management held 331,836 shares of Merck worth $42.6M as of Q2 2026.
- Van Lanschot Kempen Investment Management sold 191,123 Merck shares in Q2 2026, an estimated $22.4M.
- Merck made up 0.33% of Van Lanschot Kempen Investment Management's portfolio in Q2 2026, its #52 holding.
- Van Lanschot Kempen Investment Management first reported a position in Merck in Q4 2013 and has held it in 46 quarters since.
- Van Lanschot Kempen Investment Management's Merck position peaked at $229M in Q1 2024.
- 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.